About RG Drugs and Pharma Private Limited
Data last updated:
RG Drugs and Pharma Private Limited was a private limited company based in New Delhi, Delhi, India, operated as a subsidiary of R.G. Scientific Enterprises Private Limited. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the chemical distribution and retail segment of the chemicals and materials sector. It was incorporated on 25 April 2011.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U33110DL2011PTC218009. The company has 3 GST registrations on record, none of which is active.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Manish Bansal and Avinash Ojha.
Its last annual general meeting (AGM) was held on 10 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at F – 12 East Of Kailash, New Delhi, Delhi, India – 110065.
As per the financials filed for FY 2023, the company reported a revenue of ₹16,900. For the same year it recorded a net loss of ₹315 (net margin -1.9%) and EBITDA of -₹315 (EBITDA margin -1.9%). Revenue has declined at a compounded annual rate (CAGR) of 72% over five years.
The company was associated with 1 brand: RG Hospitals.
The last known website on record is rghospitals.com.
Company details
Contact details
RG Drugs and Pharma Private Limited's registered office is in New Delhi, Delhi. Its website is rghospitals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressF – 12 East Of Kailash, New Delhi, Delhi, India – 110065
- IndustryChemicals and Materials, Chemical Distribution & Retail
To see the full contact details of RG Drugs and Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
RG Drugs and Pharma operates one associated brand: RG Hospitals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Urology and laparoscopy treatments are provided by a hospital chain. | rghospitals.com |
Financials of RG Drugs and Pharma Private Limited
FY 2024 filings availableRG Drugs and Pharma Private Limited reported revenue of ₹16,900 for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 72% over five years. EBITDA rose 98% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹315 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹315 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -1.9% | ||||
| Net Profit Margin | -1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of RG Drugs and Pharma Private Limited, buy the company report.
Board of directors of RG Drugs and Pharma Private Limited
RG Drugs and Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manish Bansal | Director | 10 Dec 2020 | 5 Years 10 Months | As last reported |
| Avinash Ojha | Director | 06 May 2021 | 5 Years 6 Months | As last reported |
Peer comparison
RG Drugs and Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Chemicals industry (Chemical Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Windsor Specialty Resins Private Limited | ₹17,109 (FY 2022) | -99.0% | New Delhi, Delhi, India | |||
| Stepup Arogyam India Private Limited | ₹17,080 (FY 2025) | -79.0% | Surat, Gujarat, India | |||
| RG Drugs and Pharma Private Limitedthis company | ₹16,900 (FY 2023) | -₹315 | -1.9% | New Delhi, Delhi, India | ||
| Fusion De Nova Private Limited | ₹16,830 (FY 2024) | -100.0% | Chennai, Tamil Nadu, India | |||
| S.S. Texcolours Private Limited | ₹16,609 (FY 2025) | 201.0% | Jaipur, Rajasthan, India | |||
| Shivam Fuels Private Limited | ₹16,500 (FY 2025) | Delhi, India |
To see the full peer comparison of RG Drugs and Pharma Private Limited, buy the company report.
Auditor
RG Drugs and Pharma Private Limited is audited by RUDRA DATT & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RUDRA DATT & CO | FY 2022 | 032437N |
Shareholding
The shareholding of RG Drugs and Pharma Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of RG Drugs and Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving RG Drugs and Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for RG Drugs and Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
RG Drugs and Pharma has 3 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of RG Drugs and Pharma Private Limited, buy the company report.
Recent activity
RG Drugs and Pharma Private Limited has 5 board changes on record since 2020: 2 appointments and 3 cessations. The latest: Hanish Bansal ceased to be Director on 10 Oct 2024.
Frequently asked questions
RG Drugs and Pharma has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
RG Drugs and Pharma was a private limited company based in New Delhi, Delhi, India. The company worked in chemical distribution and retail, within the chemicals and materials industry. It was incorporated on 25 April 2011 and is registered under CIN U33110DL2011PTC218009. The company has been struck off by the Registrar of Companies and is no longer operational.
RG Drugs and Pharma had 2 directors:
- Manish Bansal - Director
- Avinash Ojha - Director
The CIN (Corporate Identification Number) of RG Drugs and Pharma is U33110DL2011PTC218009. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of RG Drugs and Pharma is at F – 12 East Of Kailash, New Delhi, Delhi, India – 110065.
RG Drugs and Pharma was incorporated on 25 April 2011. It is registered with the Registrar of Companies, Delhi.
RG Drugs and Pharma can be reached through the website rghospitals.com. Its registered office is in New Delhi, Delhi, India.
The latest financial statements of RG Drugs and Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 10 September 2024. Year-wise statements from 2015 are in the company report.
No. RG Drugs and Pharma has 3 GST registrations on record and all of them are cancelled or inactive.
RG Drugs and Pharma operated in the chemicals and materials industry, in the chemical distribution and retail segment. It worked in this industry before it was struck off.
The peers of RG Drugs and Pharma by revenue are Windsor Specialty Resins Private Limited, Stepup Arogyam India Private Limited, Fusion De Nova Private Limited, S.S. Texcolours Private Limited, Shivam Fuels Private Limited, all in the Chemicals industry (Chemical Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (retail trading).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
